In breast cancer, SRCIN1 expression was also found to be negatively associated with tumor malignancy, with Damiano et al. [35] demonstrating that STCIN1 was able to suppress the invasive activity of substantially metastatic breast carcinoma cells owing to its ability to suppress cortactin-dependent cell motility. This evidence concerns the gene SRCIN1 and breast carcinoma.